Benjamin I Perry1,2, Jan Stochl1,3, Rachel Upthegrove4, Stan Zammit5,6, Nick Wareham7, Claudia Langenberg7, Eleanor Winpenny7, David Dunger8, Peter B Jones1,2, Golam M Khandaker1,2,5,9. 1. Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. 2. Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom. 3. Department of Kinanthropology, Charles University, Prague, Czechia. 4. Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom. 5. Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 6. MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom. 7. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. 8. Department of Paediatrics, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. 9. MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Abstract
Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.
Importance: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. Objective: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. Design, Setting, and Participants: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. Exposures: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. Main Outcomes and Measures: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. Results: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). Conclusions and Relevance: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.
Authors: Dani Beck; Ann-Marie G de Lange; Mads L Pedersen; Dag Alnaes; Ivan I Maximov; Irene Voldsbekk; Geneviève Richard; Anne-Marthe Sanders; Kristine M Ulrichsen; Erlend S Dørum; Knut K Kolskår; Einar A Høgestøl; Nils Eiel Steen; Srdjan Djurovic; Ole A Andreassen; Jan E Nordvik; Tobias Kaufmann; Lars T Westlye Journal: Hum Brain Mapp Date: 2021-10-09 Impact factor: 5.038
Authors: Georgina MacKenzie; Sumithra Subramaniam; Lindsey J Caldwell; Denise Fitzgerald; Neil A Harrison; Soyon Hong; Sarosh R Irani; Golam M Khandaker; Adrian Liston; Veronique E Miron; Valeria Mondelli; B Paul Morgan; Carmine Pariante; Divya K Shah; Leonie S Taams; Jessica L Teeling; Rachel Upthegrove Journal: Wellcome Open Res Date: 2021-07-29
Authors: Benjamin I Perry; Frederik Vandenberghe; Nathalia Garrido-Torres; Emanuele F Osimo; Marianna Piras; Javier Vazquez-Bourgon; Rachel Upthegrove; Claire Grosu; Victor Ortiz-Garcia De La Foz; Peter B Jones; Nermine Laaboub; Miguel Ruiz-Veguilla; Jan Stochl; Celine Dubath; Manuel Canal-Rivero; Pavan Mallikarjun; Aurélie Reymond-Delacrétaz; Nicolas Ansermot; Emilio Fernandez-Egea; Severine Crettol; Franziska Gamma; Kerstin J Plessen; Philippe Conus; Golam M Khandaker; Graham K Murray; Chin B Eap; Benedicto Crespo-Facorro Journal: Lancet Reg Health Eur Date: 2022-08-19
Authors: Ulrike U Bentele; Maria Meier; Annika B E Benz; Bernadette F Denk; Stephanie J Dimitroff; Jens C Pruessner; Eva Unternaehrer Journal: J Neural Transm (Vienna) Date: 2021-05-12 Impact factor: 3.575